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Introduction. Gastroesophageal reflux has been associated with chronic inflammatory diseases and may be a cause of airway
remodelling. Aspiration of gastric fluids may cause damage to airway epithelial cells, not only because acidity is toxic to bronchial
epithelial cells, but also since it contains digestive enzymes, such as pepsin. Aim. To study whether pepsin enhances cytotoxicity and
inflammation in airway epithelial cells, and whether this is pH-dependent. Methods. Human bronchial epithelial cells were exposed
to increasing pepsin concentrations in varying acidic milieus, and cell proliferation and cytokine release were assessed. Results. Cell
survival was decreased by pepsin exposure depending on its concentration (F = 17.4) and pH level of the medium (F = 6.5) (both
P < 0.01). Pepsin-induced interleukin-8 release was greater at lower pH (F = 5.1; P < 0.01). Interleukin-6 induction by pepsin
was greater at pH 1.5 compared to pH 2.5 (mean diﬀerence 434%; P = 0.03). Conclusion. Pepsin is cytotoxic to bronchial epithelial
cells and induces inflammation in addition to acid alone, dependent on the level of acidity. Future studies should assess whether
chronic aspiration causes airway remodelling in chronic inflammatory lung diseases.
1. Introduction
Aspiration of gastric fluids damages airway epithelial cells
[1] due to the toxicity of its low pH [2]. Several in vivo and
in vitro models have assessed the eﬀect of acid aspiration
on lung injury and inflammation, using a hydrochloric acid
solution with a pH ranging from 1 to 1.5 [2–5]. In addition,
gastric particles have been found to contribute to lung injury
[6]. Previous in vivo and in vitro studies have shown that
acid aspiration causes an IL-6 and IL-8 mediated neutrophil
influx into the lungs [2, 3, 7, 8]. A correlation between acid
aspiration, increased IL-8 levels, and airway neutrophil
counts has been found in asthma patients [9]. However,
the acidity of gastric fluids might not be the only cause of
damage and inflammatory response. Digestive enzymes such
as pepsin might be an important factor as well.
Pepsin is stored as inactive pepsinogen in the chief cells of
the gastric mucosa. It is a protease involved in the digestion
of food, and its activity is acid-dependent. The conversion of
pepsinogen to pepsin in the stomach starts slowly at pH 6 and
reaches optimal activity between pH 1.5 to 2.5. Above pH 6.8,
pepsin becomes inactive and above pH 7.5 it is fully inactive
and irreversibly denatured [10]. In human gastric fluid, the
pH varies from 1.5 to 3, which agrees with pepsin’s activity
optimum, and the concentration of pepsin varies from 0.5 to
1mg/mL [11].
In recent years, pepsin has become an important and
reliable biomarker for gastric aspiration [12–14], and has
been associated with gastroesophageal reflux disease, lung
rejection after transplantation, and bronchopulmonary dys-
plasia in children [15, 16]. Experimental studies are needed
to investigate whether pepsin is solely a marker of aspiration,
or that these associations are partly caused by the pathologi-
cal actions of pepsin. The combination of protein breakdown
by pepsin and acid damage might result in an amplification
of cell and tissue damage. Pepsin in acid has been shown to
damage the esophageal tissue of rabbits, more so than acid
alone [17]. The cytotoxicity and inflammation caused by a
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combination of acid and pepsin on airway epithelium has,
until now, not been investigated.
To assess the additional eﬀect of pepsin in inducing in-
flammation and cytotoxicity to airway cells, we briefly ex-
posed bronchial epithelial cells to various pH levels with and
without pepsin. We hypothesised that pepsin concentrations
at a lower pH would result in increased cytotoxicity and in-
duce proinflammatory cytokine release.
2. Methods
All reagents were obtained from Sigma-Aldrich, United
Kingdom unless otherwise stated.
2.1. Cell Culture. Human bronchial epithelial cells (16-HBE,
an SV-40 transformed cell-line) were maintained in contin-
uous culture in Dulbecco’s Modified Eagle’s Medium sup-
plemented with 10% heat-inactivated fetal bovine serum,
2mM glutamate, and penicillin (100 IU/mL)/streptomycin
(100 μg/mL). Cells were grown to confluency at 37◦C in a
humidified atmosphere containing 5% CO2, washed with
Ca2+/Mg2+-free phosphate-buﬀered saline (PBS-CMF), har-
vested with Trypsin-EDTA, and passaged.
The cells were seeded at a density of 60,000 per well in
24-well culture plates, and grown until approximately 80%
confluent in complete media.
2.2. Experimental Model of Gastric Fluid Aspiration. 0.01M
hydrochloric acid (26mL, 13mL, and 10mL) was added to
cell culture medium (25mL) until pH was 1.5, 2, and 2.5,
respectively. Pepsin concentrations of 40, 20, 10, 5, 2.5, and
1.25mg/mL in 0.9% sodium chloride were prepared. Cell
media was discarded and the wells were washed with PBS-
CMF. One hundred μL of pepsin solution was added to
900 μL of acidified culture medium in the wells, and cells
were exposed for 5 minutes to pepsin in each of the com-
binations of acidified culture medium, resulting in final pep-
sin concentrations of 4, 2, 1, 0.5, 0.25, and 0.125mg/mL.
Exposure medium was removed and cells were incubated
for 20 hours in culture medium. Medium was centrifuged;
cytotoxicity and cytokines were assessed in the supernatant.
Each experiment was performed 3 times in duplicate.
2.3. Assessment of Cytotoxicity and Cytokine Release. Viability
of cells was assessed by lactate dehydrogenase (LDH) (Roche
Molecular Biochemicals, West Sussex, United Kingdom)
release using pyruvic acid as a substrate and cell prolifer-
ation by Methylene Blue staining [18] by spectrometry. In-
terleukin-1β (IL-1β), IL-5, IL-6, IL-8, IL-10, tumor necrosis
factor-α (TNF-α), and vascular endothelial growth factor
(VEGF) were measured by a cytometric bead array (BD Bi-
osciences, Oxford, United Kingdom).
2.4. Statistics. Cell proliferation was expressed as an absorp-
tion percentage of the media control without pepsin with
corresponding pH; cytokine levels were corrected for cell
proliferation and expressed as a percentage of the level of the
corresponding pH without pepsin. Cytotoxicity measured
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Figure 1: Exposure of cells for 5 minutes induced more cytotoxicity
as measured by LDH after 20 hours incubation at pH 2.0 (mean
(SEM) 57% ± 5.77%) compared to both pH 1.5 and pH 2.5 (22% ±
2.17%, and 28% ± 2.81%, resp., both P < 0.01). LDH release was
pH-dependent (P < 0.01). There was a trend for a pepsin eﬀect (P =
0.078), with lower LDH release with pepsin at all concentrations
compared to no pepsin, independent of pH levels.
by LDH was expressed as an absorption percentage of ex-
posure to 100% lysis (by Triton X). Cell proliferation, LDH
cytotoxicity, and cytokine levels were analysed using a 2-
way ANOVA with pepsin concentration with pH as a fixed
factor, and Tukey post-hoc testing. We considered P < 0.05
as statistically significant. All data were analysed using the
SPSS statistical package for Windows, version 12.0.1 (SPSS
inc, Chicago, Illinois).
3. Results
3.1. Cytoxicity. Acidification of the cell culture induced
cytotoxicity asmeasured by LDH significantlymore at pH 2.0
(mean (SEM) 57% ± 5.77%) compared to both pH 1.5 and
pH 2.5 (22% ± 2.17%, and 28% ± 2.81%, resp., both P <
0.01, Figure 1). LDH-release therefore was pH-dependent
(P < 0.01). There was a trend for a pepsin eﬀect (P = 0.078),
with lower LDH release with pepsin at all concentrations
compared to no pepsin, independent of pH levels.
The exposure of cells to media with pH 1.5 for 5 minutes
resulted in significantly less cell survival after 20 hours of
incubation compared to pH 2.5 (mean absorption 0.22
versus 0.57; P = 0.03, Figure 2). The addition of pepsin
caused a decrease in cell survival, which was dependant on
both pepsin and pH (both P < 0.01, Figure 3 and sup-
plemental Figure 1 in Supplementary Material online at doi:
10.4061/2011/569416). The eﬀects of pepsin and acidified
medium on cell survival were interactive (P < 0.01). Pepsin,
resulted in lower cell survival compared to no pepsin at pH
1.5 at all concentrations tested (P < 0.01). At pH 2 and pH
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Figure 2: pH dependence of 16-HBE cell survival, as measured by
methylene blue absorption. ∗Exposure of cells to medium with pH
1.5 for 5 minutes resulted in significantly less cell proliferation after
20 hours of incubation compared to exposure to pH 2.5 (mean
absorption 0.22 versus 0.57; P = 0.03, n = 3). pH of control
medium was 7.9. Histograms represent the means and the bars the
SEM.
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Figure 3: Eﬀects of pepsin on cell survival, as measured by
methylene blue absorption, and expressed as a % of absorbance
of treatment with the corresponding pH without pepsin (control).
Pepsin induced a significant decrease in cell survival independent of
pH (F = 6.5; P < 0.01). Data are expressed as means (histograms)
and SEM (bars) for 3 replicates. See supplement Figure 1 for the
eﬀect of pepsin on cell survival of all the pH levels used in the
statistical analysis.
2.5, there were trends towards lower cell survival with higher
pepsin concentrations.
3.2. Cytokine Release. Figure 4 shows the eﬀects of pepsin,
dependent on dose and pH level, on IL-6 release. There was
a trend towards more IL-6 release induced by pepsin after
exposure to media with a lower pH (P = 0.09). Posthoc
analysis showed that exposure at a pH of 1.5 resulted in
a greater induction of IL-6 release by pepsin compared to
pH 2.5 for all pepsin concentrations (mean diﬀerence 283%;
P = 0.03) (see Figure 4 and supplement Figure 2).
The induction of IL-8 release by pepsin was greater at
lower pH levels (P < 0.01). Pepsin at a pH of 1.5 induced
significantly more IL-8 compared to pH 2.5 for all pepsin
concentrations (mean diﬀerence 221%; P < 0.01, Figure 5,
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Figure 4: Interleukin-6 production by 16-HBE cells, corrected
for cell proliferation and expressed as a % of exposure with the
corresponding pH without pepsin (control). Interleukin-6 release
induced by pepsin is higher at pH 1.5 compared to pH 2.5
(mean diﬀerence 283%; P = 0.03). Data are expressed as means
(histograms) and SEM (bars) for 3 replicates. See supplement
Figure 2 for induction of IL-6 at all pepsin concentrations and pH
levels used in the statistical analysis.
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Figure 5: Interleukin-8 production by 16-HBE cells, corrected
for cell proliferation and expressed as a % of exposure with the
corresponding pH without pepsin (control). Interleukin-8 release
induced by pepsin is higher at pH 1.5 compared to pH 2.5 (mean
diﬀerence 221%; P < 0.01). Data expressed as mean (histograms)
and SEM (bars) for 3 replicates. See supplement Figure 3 for
induction of IL-8 at all pepsin concentrations and pH levels used
in the statistical analysis.
and supplement Figure 3). We were unable to detect VEGF-
B with pH 1.5 and pH 2. With pH 2.5, there was no eﬀect of
pepsin on VEGF-B release. IL-1β, IL-5, and TNF-α were not
detected.
4. Discussion
We found that pepsin is cytotoxic and induces inflammation
in bronchial epithelial cells. Pepsin-induced cytotoxicity to
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16HBE cells is pH-dependent, with the greatest eﬀect seen at
the lowest acidity. Likewise, pepsin-mediated IL-6 and IL-8
release is greatest in media with a lower pH.
We assessed cell damage by both lactate dehydrogenase
(LDH) release from airway epithelial cells that indicated dis-
ruption of the cell membrane and Methylene Blue staining
of, predominantly, nucleic acids. Methylene Blue is generally
used to measure cell proliferation, and also gives an indi-
cation of cell damage due to detachment. The LDH assay
showed lower levels with more toxic concentrations of pH
and pepsin. This is probably due to the removal of medium
used during cell exposure before incubation, which resulted
in removal of the LDH released in the first 5 minutes.
Therefore, our study does not report an acute toxic eﬀect at
least as measured by LDH release.
A disadvantage of assessing cell number with Methylene
Blue might be the loss of living cells when the exposure
medium is exchanged for incubation medium: pepsin may
destroy adhesion molecules, resulting in free floating live
cells, which could be lost during the removal of the medium.
Acid exposure makes the cells more susceptible, facilitating
greater cell detachment by pepsin. To minimise loss of cells
due to detachment, we did not wash the wells after exposure,
but carefully removed the exposure medium. Nonetheless, it
is quite possible that we lost live cells during this procedure.
In vivo studies have found that destruction of junctional
molecules by pepsin causes erosive lesions in the oesophageal
epithelium, and similar lesions have been found in the
airways due to gastric fluid aspiration [1, 17]. We did not
determine, in our model, the number of cells that were lost
due to detachment or due to cell death.
We used an experimental protocol that is very cytotoxic:
we had to expose cells to low pH levels, since pepsin requires
a pH of 3 or under to become activated [17]. Therefore, we
corrected for cell number to analyse cytokine release. We
assessed exposure times of 5 minutes and 1 hour, but found
the 1 hour exposure time to be markedly toxic to the cells
due to extended exposure to low pH. Likewise, the cells were
exposed in full media, containing physiologically relevant
10% serum, to oﬀer some protection, since preliminary ex-
periments (not shown) showed that the low pH and pepsin
were very toxic. However, it should be noted that acidifying
the medium with HCl to the various pH levels would have
resulted in dilution of the medium causing changes in the
osmolarity, as well as changes in the medium due to reaction
of HCl with media components. Thus, we expressed the re-
sults of the eﬀects of pepsin as a ratio to the medium of the
corresponding pH without pepsin to correct for this bias.
Chronic aspiration has been associated with chronic in-
flammatory lung diseases. There are few data on the conse-
quences of chronic aspiration. It is tempting to hypothesise
that chronic aspiration leads to airway remodelling and the
development of COPD, since recent reports suggest strong
associations between COPD and gastroesophageal reflux
disease [19–21]. Whether aspiration is the cause of this asso-
ciation is unknown. Our in vitro model shows that aspiration
could lead to direct epithelial damage and the release of
inflammatory mediators, involving at least the cytokines IL-
6 and IL-8. These cytokines are involved in recruitment of
neutrophils, and induction of acute phase reactants, and are
increased in sputum during COPD exacerbations [22]. Mod-
els of chronic aspiration are required to determine which
consequences our acute observations have in the develop-
ment of COPD. Since we found cytotoxic and pro-inflam-
matory eﬀects of pepsin in addition to those caused by acids
alone, future studies investigating the consequences of
chronic aspiration should include pepsin in aspiration mod-
els. Future human studies should assess whether chronic as-
piration causes airway remodelling.
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